Field evaluation of a rapid immunochromatographic assay for detection of Trypanosoma cruzi infection by use of whole blood 1. Médecins Sans Frontières.

Slides:



Advertisements
Similar presentations
, MAIN RESULTS INTEGRATION OF A RAPID TEST INTO FRENCH GUIDELINES IN ORDER TO IMPROVE TETANUS PROPHYLAXIS IN PATIENTS PRESENTING WITH WOUNDS TO EMERGENCY.
Advertisements

RESULTS: After Discordant Analysis RESULTS: Discordant Testing
Clinical Performance of the APTIMA HPV Assay for Detection of E6/E7 mRNA from High-Risk HPV Types in Liquid Based Cytology Specimens C. Hill1, J. Dockter1,
+ Colombia What do you know about? Viviam Patricia Cañon G Internal Medicine – Infectious Diseases
Performance of a diagnostic test
TESTS USED IN BLOOD SCREENING French Blood Services (EFS)
Chagas Tests: Development and Standardization
Amadeo Sáez-Alquézar Second WHO Consultation: Development of a WHO reference panel for the control of Chagas diagnostic tests Geneva Development.
Planning Laboratory Support for HIV, TB and Malaria Procurement and Supply Management Workshop for SEARO and WPRO Countries 25 – 30 July 2005 Bangkok,
CHAGAS DISEASE Overwiev Diagnosis Proposals for WHO Ref.Preparation Alejandro O. Luquetti Laboratório de Pesquisa em Doença de Chagas Hospital das Clínicas.
WHO Consultation Meeting January 2009 Quality Control of Chagas diagnostics immunoassays: Assay characteristics and manufacturers reference panels.
Standardization of PCR for Trypanosoma cruzi detection
Module 4: HIV Testing Strategies and Algorithms. 2 Learning Objectives At the end of this module, you will be able to: Discuss the process for developing.
Nick Curry, MD, MPH Infectious Diseases Prevention Section
1 From the analytical uncertainty to uncertainty in data interpretation D. Concordet, J.P. Braun
Combined Rapid and HIV RNA Testing in a Public STD Clinic: San Francisco, Jeffrey D. Klausner, Susan Philip, Katherine Ahrens, Giuliano Nieri,
High Throughput Donor Plasma NAT Screening Assay Applied to Acute HIV Detection in a Public Health Setting December 5, 2007 Josh Goldsmith, Ph.D. National.
HCV Assays: Impact on HCV Studies & Update on HCV blood bank protocol.
Implementing Rapid HIV Testing: Technologies, Legal and Cost Issues Vanessa Lee, MPH HIV Rapid Testing Coordinator CA Office of AIDS.
Unit 5: Choosing an HIV Test
Rapid Diagnostic Tests for Syphilis A Preliminary Review of the U. S
Replacement of the 1 st Parvovirus B19 DNA International Standard SoGAT XXI, Brussels, 28th-29th May 2009 Sally Baylis.
Global Consultation on the Implementation of the Xpert MTB/RIF system for rapid diagnosis of TB and MDR-TB M. Akhalaia, MD, Microbiologist, Reference.
VANDERBILT HOME CARE SERVICES Quality Of Documentation Of Rehab Staff Over The Course Of Patient Treatment.
CHAGAS DISEASE Serological Diagnosis and the humoral immune response after specific treatment Alejandro O. Luquetti & Anis Rassi Laboratório de Pesquisa.
Rowena Hockings, David Schmidt, Christopher Cheung
Palermo – April 26, 2014 Controlling the quality of diagnostic tests E. Bravi.
Results of a smoking cessation intervention programme in the workplace: lessons learnt Dr. Timea TOTH Ruzsas E, Biro B, Olajos A, Nikl A, Jelencsics Zs.
Lecture 3 Validity of screening and diagnostic tests
Access to Health Care in Africa : Laboratory Diagnostics Cape Town, April 16 –
Lets play bingo!!. Calculate: MEAN Calculate: MEDIAN
Addition 1’s to 20.
Performance PLG 3 rd August, 2011 Richard Wells, Head of Knowledge & Intelligence Performance Report.
Human Papillomavirus 16: Prevalence, Incidence, and Behavioral Risk Factors Deborah L. Thompson, MD, MSPH March 10, 2004.
2 Graphs and Functions © 2008 Pearson Addison-Wesley. All rights reserved Sections 2.8.
Assessment of three new parasite lactate dehydrogenase (pan-pLDH) tests for diagnosis of uncomplicated malaria Assessment of three new parasite lactate.
Improving direct microscopy by overnight bleach sedimentation: a simple tool for peripheral Health Centres Maryline Bonnet 1, Laramie Gagnidze 1, Willie.
WHO comparative evaluation of serologic assays for Chagas disease Journal Club April 2, 2009.
Improved Reflexive Testing Algorithm for Hepatitis C Infection Using Signal-to-Cutoff Ratios of a Hepatitis C Virus Antibody Assay K.K.Y. Lai, M. Jin,
An Introduction to HIV Incidence Surveillance (HIS) in California California Department of Public Health Office of AIDS.
Evaluation of Xpert MTB/RIF Assay for the Rapid Identification of TB and Rifampin Resistance in HIV Infected & HIV uninfected Pulmonary TB suspects: ACTG.
Kuala Lumpur, Malaysia, 30 June - 3 July 2013 Prevalence of anal Human Papillomavirus (HPV) infection and anal squamous intraepithelial.
DEPARTMENT OF HEALTH RESEARCH INSTITUTE FOR TROPICAL MEDICINE Ebola Virus Disease Diagnosis Catalino S. Demetria, DVM.
International Symposium Centenary of Chagas Disease Use of Polymerase Chain Reaction (PCR) to Establish Drug Efficacy - Value and Limitations.
Enzyme-Linked Immunosorbent Assay (ELISA) Mary Lea Killian USDA APHIS VS National Veterinary Services Laboratories Ames, Iowa.
OnSite HAV IgM Rapid Test Upgraded to Revision H for Better Sensitivity CTK-MK-PPT-R0090 Rev 1.0.
OnSite Rubella IgG/IgM Rapid Test Novel Unique & Only Semi-Quantitative 4-Line Rapid Test.
OnSite Leishmania Ab Rapid Test (Strip) Leishmania IgG / IgM Rapid Test A Leading Product On Market by Using CTK Licensed Patented Antigen.
CLINICAL TRIAL OF THE HEMA-STRIP HIV RAPID TEST USING FINGERSTICK BLOOD, WHOLE BLOOD, PLASMA, AND SERUM Niel T. Constantine 1, Dan Bigg 2, Daniel Cohen.
An assessment tool for dactylitis Philip Helliwell.
OnSite Dengue Rapid Test.
Estimating the impact of daycare on child development and women welfare Washington, April 2008 Ricardo Barros - IPEA Mirela de Carvalho – IPEA Laura Domingues.
Development of Standard Reagents for WNV NAT M. Rios, A. Grinev, K. Sirnivasan, O. Wood, S. Daniel, I. Hewlett CBER/FDA.
Panbio Dengue Duo Cassette
Indicators in Malaria Program Phases By Bayo S Fatunmbi [Technical Officer, Monitoring & Evaluation] ERAR-GMS, WHO Cambodia.
PROPOSED CANDIDATE MATERIAL FOR A WHO PANEL FOR SEROLOGICAL REFERENCE RESULTS OF THE FEASIBILITY STUDIES WITH SERA FROM TC I REGION RESULTS OF THE FEASIBILITY.
Quality control & Statistics. Definition: it is the science of gathering, analyzing, interpreting and representing data. Example: introduction a new test.
Malaria pan-R Malaria cassette. Agenda Disease overview Infectious agents Diagnosis pan-R Malaria cassette: specifications Conclusion.
Blood Products Advisory Committee Meeting April 26, 2007 Ben Marchlewicz, Ph.D. PRISM R&D, Program Manager.
Biochemical and ultrastructural study of the interaction process between Rhodnius prolixus and Trypanosoma rangeli Universidad del Este Kate Katherine.
 Remember Chemistry panel Quality Control:-  In a medical laboratory, it is a statistical process used to monitor and evaluate the analytical process.
Proposed candidate materials and results of the feasibility studies for a WHO serological reference panel T.cruzi type II Márcia Otani Fundação Pró-Sangue.
COMPARISON OF LABORATORY DIAGNOSTIC PROCEDURES FOR DETECTION OF MYCOPLASMA PNEUMONIAE IN COMMUNITY OUTBREAKS KATHLEEN A. THURMAN, NICHOLAS D. WALTER, STEPHANIE.
Evaluation of SAMBA Viral Load point-of-care test operation by trained non-health workers in rural Health Centers, Chiradzulu District, Malawi Birgit.
INSTITUTO DE INFECTOLOGIA EMÍLIO RIBAS
Rapid Diagnosis of Dengue virus
What is Screening? Basic Public Health Concepts Sheila West, Ph.D.
Practical clinical chemistry
What is Screening? Basic Public Health Concepts Sheila West, Ph.D.
Rose Nyirenda Ministry of Health, Malawi
Presentation transcript:

Field evaluation of a rapid immunochromatographic assay for detection of Trypanosoma cruzi infection by use of whole blood 1. Médecins Sans Frontières – Spain 2. Universitario de Medicina Tropical - Universidad Mayor de San Simon, Bolivia 3. Instituto Oswaldo Cruz - Fiocruz, Rio de Janeiro, Brazil Paul Roddy June 2008

ELISA Conventional IHA ELISA Recombinant

Study Rationale Sensitivity and specificity when using whole blood was unknown. Circumvent constraints associated with conventional serological assays and bolster Chagas disease control efforts.

Objectives Evaluate Measure Compare

Methods (1/4) - study location and participants April – June 2007 Valle Hermoso district - Sucre municipality (pop. = 46,000) 9-months to 17.9 years (pop. = 19,000)

Methods (2/4) – diagnostic test procedures 10 microliters (µL) of whole blood. Independently interpreted at 15 minutes. 3.5 millilitres (mL) of whole blood. 2 out of the 3 conventional assays are positive.   Benznidazole treatment offered.

Methods (3/4) – laboratory quality control Quality control applied at health clinic and laboratory levels. Calibrations Positive and negative serum controls ‘Good practices’ check list Internal and external quality control

Methods (4/4) – measurements of diagnostic test performance Sensitivity and specificity calculated. The inter-observer reliability measured = kappa statistic. The ‘ease of use’ criterion were quantified and compared.

Results – demographics 1,913 study participants M:F ratio = 0.95 Mean age = 9.3 years (SD= 4.4) Median age = 9.0 years (interquartile range = 6-13)

Results – sensitivity & specificity 93.4% sensitivity (95% CI: 87.4% - 97.1%) 99.0% specificity (95% CI: 98.4% - 99.4%) Stat-Pak Conventional Serology   Positive Negative Total Positive 113 18 131 Negative 8 1774 1782 Total 121 1792 1913

Results – inter-observer reliability Trained, non-laboratory health workers concurred on 1,911 of 1,913 test results yielding: 99.9% overall agreement kappa = .999 (p<.0001)

Results – ease of use criterion Questionnaire items scored according to a scheme outlined in the Methods section of the article. Total of 51 possible points: Chagas Stat-Pak = 39.25 points (77%) IHA assay = 34 points (67%) ELISA conventional = 30 points (59%) ELISA recombinant = 30 points (59%)

Possible limitation Cross-reactivity may occur between sera of patients infected with T. cruzi and sera of patients infected with Leishmania spp. when using conventional assays for the diagnosis of Chagasic infections. 8 / 121 = 6.6%

Conclusion and Recommendations (1/2) Effective laboratory-based solutions not widely available or likely to be anytime in the near future. RDT cost remains ‘out of reach’ for many impoverished people affected by the disease. Compares less favorably with whole-blood RDT diagnosis of other parasitological vector-borne diseases.

Conclusion and Recommendations (2/2) Missed treatment opportunities and increased likelihood of chronic-stage disease sequela. Not an ideal screening or diagnostic test for the population investigated in this study. Hindered ability of the test to give dependable results under the conditions outlined in the study. MSF continues to use whole blood with the Chagas Stat-PakTM RDT…